Baloxavir Marboxil
CAS 1985606-14-1 5 FDA-DMF suppliersSmall Molecule
Overview
Baloxavir Marboxil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297503).
API suppliers (5)
Suppliers of Baloxavir Marboxil backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF
- Porton Pharma Solutions Ltd.China1 active DMF
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina1 active DMF
- SUZHOU VDOBIOTECH CO LTDChina1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Baloxavir Marboxil expires 21 Apr 2041 and exclusivity 19 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate
- Canonical SMILES
- COC(=O)OCOC1=C2C(=O)N3CCOC[C@H]3N(N2C=CC1=O)[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F
- InChIKey
- RZVPBGBYGMDSBG-GGAORHGYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.